M. Alexander Otto
- News- Study calls higher surgery costs at NCI centers into question- September 1, 2021- When is the higher cost of cancer surgery at NCI centers worth it? 
- News- Even patients with cancer in remission at risk for severe COVID-19- January 26, 2021- Cancer patients, regardless of their age, and even if they are in remission, should be prioritized for vaccination against COVID-19. 
- News- A 4-point thrombocytopenia score was found able to rule out suspected HIT- January 11, 2021- A low score – 3 points or less – has a negative predictive value of 99.8%, “so HIT is basically ruled out.” 
- News- Cost is the main hurdle to broad use of caplacizumab for TTP- December 7, 2020- “If we take finances out, I think almost every patient except those with a bleeding risk or bleeding problem should get it,” an investigator said. 
- News- What to do when anticoagulation fails cancer patients- December 1, 2020- When it comes to “anticoagulation failure, we are entering an evidence free-zone.” 
![1]() - News- COVID-19 in pregnancy: Supplement oxygen if saturation dips below 94%- May 8, 2020- Use high-flow nasal cannula, not positive-pressure ventilation. 
- News- Results from 11 AHA-funded COVID-19 studies expected within months- May 7, 2020- The AHA’s COVID-19 and Its Cardiovascular Impact Rapid Response Grant initiative awards $1.2 million in grants. 
![1]() - News- Case series suggests biologics, JAK inhibitors safe during pandemic- May 1, 2020- Investigators saw no increase in hospitalizations versus the general population in New York City. 
- News- Yale’s COVID-19 inpatient protocol: Hydroxychloroquine plus/minus tocilizumab- April 30, 2020- Yale cardiologist offers lessons from “the haze of battle” on fighting COVID-19 with little evidence. 
![1]() - News- Protean manifestations of COVID-19: “Our ignorance is profound”- April 17, 2020- “Make sure they didn’t die in vain.” 


